Literature DB >> 2596457

Questionable clinical significance of Blastocystis hominis infection.

T Sun1, S Katz, B Tanenbaum, C Schenone.   

Abstract

In the period from January 1986 to July 1988, Blastocystic hominis was found in moderate and numerous quantities in 103 (1.6%) of 6,262 stool specimens examined in our laboratory. There was no significant association of the detection of B. hominis with travel history or symptoms. Indeed, 20 patients (36%) with moderate to heavy infections had no gastrointestinal symptoms, and three symptomatic patients did not show clinical improvement after elimination of the parasite. Reexamination of stool samples revealed that eight untreated patients had spontaneous disappearance of B. hominis. We conclude that B. hominis probably is not responsible for clinical symptoms when detected, and additional investigations should be pursued for other etiologies of the patient's symptoms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596457

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Pathogenicity of Blastocystis hominis.

Authors:  C H Zierdt
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 2.  Enteric parasitology. Interpreting laboratory reports.

Authors:  D W MacPherson
Journal:  Can Fam Physician       Date:  1995-10       Impact factor: 3.275

Review 3.  Blastocystis hominis revisited.

Authors:  D J Stenzel; P F Boreham
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  High occurrence of Blastocystis sp. subtype 3 in individuals referred to medical laboratories in Kermanshah, Iran.

Authors:  Bahman Maleki; Javid Sadraei; Abdolhossein Dalimi Asl; Majid Pirestani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

Review 5.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  PCR-based subtyping of Blastocystis isolates from symptomatic and asymptomatic individuals in a major hospital in Ankara, Turkey.

Authors:  Funda Dogruman-Al; Hisao Yoshikawa; Semra Kustimur; Neriman Balaban
Journal:  Parasitol Res       Date:  2009-10-22       Impact factor: 2.289

7.  Expression of interferon gamma and proinflammatory cytokines in the cecal mucosa of rats experimentally infected with Blastocystis sp. strain RN94-9.

Authors:  Aya Iguchi; Hisao Yoshikawa; Minoru Yamada; Isao Kimata; Naoki Arizono
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

8.  Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

Authors:  Kenneth F Boorom; Huw Smith; Laila Nimri; Eric Viscogliosi; Gregory Spanakos; Unaiza Parkar; Lan-Hua Li; Xiao-Nong Zhou; Ulgen Z Ok; Saovanee Leelayoova; Morris S Jones
Journal:  Parasit Vectors       Date:  2008-10-21       Impact factor: 3.876

9.  Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands.

Authors:  Aldert Bart; Ellen M S Wentink-Bonnema; Henk Gilis; Nienke Verhaar; Carla J A Wassenaar; Michèle van Vugt; Abraham Goorhuis; Tom van Gool
Journal:  BMC Infect Dis       Date:  2013-08-23       Impact factor: 3.090

10.  Higher Caspase-like activity in symptomatic isolates of Blastocystis spp.

Authors:  Dhurga D Balakrishnan; Suresh G Kumar
Journal:  Parasit Vectors       Date:  2014-05-12       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.